Drugs / Lactulose Oral Liquid Product
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05144295 Comparator | Jan → Aug 2022 | — | Alexandria University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactulose Oral Liquid Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05144295 ↗ |
| Known as | Duphalac | “Lactulose " Lactulose, or Duphalac syrup" at a dose of 1 ml/kg once or twice daily (maximum 60 mL/day)” NCT05144295 ↗ |
| Route | Oral | “Lactulose Oral Liquid Product” NCT05144295 ↗ |